Dubai-Primarily based Opulence Capital Invests $ 20 Million in Nano Cures for World Growth


Nano Cures, a biotechnology and clinical-stage infectious illness immunity platform firm, acquired a $ 90 million funding spherical forward of the IPO, together with $ 20 million from Opulence Capital Administration, a non-public fairness fund based mostly in Dubai. This funding will speed up the worldwide scale-up of the Nano’s Cures platform for Covid-19 variants, together with vaccines and chronic supply of immunity. The corporate will open its Cures platform to different pharmaceutical corporations and their vaccines, providing dynamic new methods to beat the pandemic and ship billions of doses on to these in want.

Steve papermasterMentioned the CEO of Nano, “As Covid-19 has made clear, a twenty first century know-how method is required to actualize how we proactively resolve public well being challenges and threats. The deployment of the Nano Cures platform will assist heal the world from the present devastating Covid-19 pandemic and defend it from future pandemics, epidemics and pointless deaths from infectious illnesses. The chance to take action is presumably the best worth creation alternative on this planet at the moment. “

Nano is accelerating plans to convey its Cures platform for Covid-19 (and its variants) to rising areas such because the GCC, Southeast Asia, Latin America and Central / Southern Europe. Breakthroughs in disruptive supply strategies past injections shall be a game-changer in bettering entry and supply of vaccines to populations in all areas.

“We’re proud to help and companion with Nano in bringing this Cures platform to market. We imagine they supply a really distinctive set of proactive well being and security options to take care of the present international pandemic, in addition to to protect towards the subsequent, ”mentioned Alexander Vanderhey, president of Opulence Capital Administration. “With this funding, we envision a safer and more healthy future for the world.”

Nano is growing common coronavirus vaccines and therapies for annual safety towards recognized and rising coronaviruses, which shall be important for efficiently avoiding future international and regional well being and financial threats.


About Author

Comments are closed.